FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/029618 [Registered on: 07/12/2020] Trial Registered Prospectively
Last Modified On: 29/03/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Biological
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of Ayurvedic treatment in chronic simple rhinitis 
Scientific Title of Study   Randomized Controlled Trial To Evaluate Efficacy Of Nidigdhikadi Kwatha In Management Of Peenasa (Chronic Simple Rhinitis) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vd Sandip Patil 
Designation  MS Scholar Shalakyatantra (Ayurved) 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  OPD no. 08, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Malwadi Road, Hadapsar

Pune
MAHARASHTRA
411028
India 
Phone  8379890248  
Fax    
Email  patilsandip771@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR PRAVIN M BHAT 
Designation  Associate Professor 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  OPD no. 08, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Malwadi road, Hadapsar

Pune
MAHARASHTRA
411028
India 
Phone  09860233173  
Fax    
Email  vdpravin82@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR PRAVIN M BHAT 
Designation  Associate Professor 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  OPD no. 08, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Malwadi road, Hadapsar

Pune
MAHARASHTRA
411028
India 
Phone  09860233173  
Fax    
Email  vdpravin82@gmail.com  
 
Source of Monetary or Material Support  
Department of Shalakyatantra, Sane Guruji Arogya Tantra, Malwadi road, Hadapsar, Pune. 
 
Primary Sponsor  
Name  Sane Guruji Arogya Kendra 
Address  Sane Guruji Arogya kendra, Malwadi road, Hadapsar, Pune. 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vd Sandip Patil  Sane Guruji Arogya Kendra  Opd no 8, Department of Shalakyatantra,Sane Guruji Arogya Kendra,Malwadi road,Hadapsar
Pune
MAHARASHTRA 
8379890248

patilsandip771@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J310||Chronic rhinitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Levocetirizine(5mg) with Phenylephrine (10mg)  Levocetrizine 5mg in combination with Phenylephrine 10mg orally daily at night for 21 days 
Intervention  Nidigdhikadi Kwatha  Nidigdhikadi Kwatha, Orally 20ml,(In single dose) for 21 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Patients fulfilling the diagnostic criteria of Peenasa(Chronic Simple Rhinitis).
2) Patients suffering from three or more the following symptoms for more than one months were selected for study.( Nasal obstruction, Nasal discharge, Headache , Swollen turbinate’s, Post-Nasal discharge )
3) A patients having age group 18 to 60 years.
4) Patient willing to participate in the study.
5) Patients were recruited irrespective of sex, religion, occupation. 
 
ExclusionCriteria 
Details  1) Pregnant women and Children.
2) Patients with history of congenital disorder of Nose.
3) Patients suffering from gross deviation of nasal septum and associated with other nasal pathology like nasal polyp etc.
4) Patients with uncontrolled systemic diseases like Diabetes Mellitus and Hypertension.
5) Chronic simple Rhinitis associated with Hyperthyroidism, Exanthemas, Adenoidal Hyperplasia, Choanal Atresia and Nasal Tumors.
6) Patient having Angle-Closure Glaucoma and Pyloric Stenosis. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Primary outcome will be evaluation of efficacy of Nidigdhikadi Kwatha in Peenasa Vyadhi w.r.t Chronic Simple Rhinitis  The drug will be given for 21 days.The efficacy will be assessed on the basis of VAS SCALE for symptoms before and after treatment. The patients will be assessed before and after treatment. Total duration of the study will 18 months. 
 
Secondary Outcome  
Outcome  TimePoints 
A comparison between efficacy
of Nidigdhikadi Kwatha and Tab Levocetrizine 5mg
in combination with Phenylephrine 10mg in
Peenasa Vyadhi w.r.t Chronic Simple Rhinitis will be done 
Total duration of study is 18 Months. Baseline assessment will be done of each patient before and after treatment. Each patient will be treated for 21days. Assessment will be done on VAS SCALE 
 
Target Sample Size   Total Sample Size="74"
Sample Size from India="74" 
Final Enrollment numbers achieved (Total)= "68"
Final Enrollment numbers achieved (India)="68" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/03/2021 
Date of Study Completion (India) 02/09/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   None Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is open labelled randomized controlled clinical trial to evaluate the effect of Nidigdhikadi Kwatha daily orally once in a day for 21days in comparison with Tab Levocetrizine 5mg in combination with Phenylephrine 10mg at night in patients affected with Peenasa Vyadhi w.r.t Chronic Simple Rhinitis. The Primary outcome will be effect of Nidigdhikadi Kwatha and the secondary outcome will be comparison between trial drug and control drug in management of Peenasa Vyadhi w.r.t Chronic Simple Rhinitis 
Close